Wasman Jane
SEC insider (Form 3/4/5 filer). CIK 0001352455. Director at RIGEL PHARMACEUTICALS INC (RIGL) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on May 15, 2026. Located in NEW YORK, NY.
Companies Wasman Jane has filed insider reports for
- RIGEL PHARMACEUTICALS INC (RIGL): Director
- SELLAS Life Sciences Group, Inc. (SLS): Director
Wasman Jane
CIK: 0001352455
Transaction Breakdown
Open Market Buys (P)1 (20.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (80.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- May 15, 2026RIGL
RIGEL PHARMACEUTICALS INC
AwardDirect5.8K shares- - Jan 7, 2026SLS
SELLAS Life Sciences Group, Inc.
AwardDirect50K shares- - May 30, 2025SLS
SELLAS Life Sciences Group, Inc.
PurchaseDirect20K shares at avg. $1.69$34K - May 23, 2025RIGL
RIGEL PHARMACEUTICALS INC
AwardDirect2.5K shares- - Jan 10, 2025SLS
SELLAS Life Sciences Group, Inc.
AwardDirect12.5K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 15, 2026 |  RIGL RIGEL PHARMACEUTICALS INC | Award | 5,750 | - | $0 | Direct |
| Jan 7, 2026 |  SLS SELLAS Life Sciences Group, Inc. | Award | 50,000 | - | $0 | Direct |
| May 30, 2025 | SLS SELLAS Life Sciences Group, Inc. | Purchase | 20,000 | $1.69 | $33,800 | Direct |
| May 23, 2025 | RIGL RIGEL PHARMACEUTICALS INC | Award | 2,500 | - | - | Direct |
| Jan 10, 2025 | SLS SELLAS Life Sciences Group, Inc. | Award | 12,500 | - | $0 | Direct |
1-5 of 5 transactions